Polymerase chain reaction (PCR) and ligase chain reaction (LCR) were compared for the diagnosis of Chlamydia trachomatis infections by testing urine specimens from 408 high school female students. After therapy, sequential urine specimens were tested to determine persistence of chlamydial DNA in urine. Baseline PCR of cervical specimens was positive in 53 (13.0%) students, and PCR and LCR of urine specimens were positive in 63 (15.4%) and 60 (14.7%), respectively. After discrepant analysis, 64 (15.7%) patients could be confirmed as truly infected. Follow-up urine specimens from 33 infected patients demonstrated that at 1 -3 days after therapy, PCR and LCR were positive for 40% and 73.3%, respectively. Only at 15 days after therapy did all specimens test negative. Urine tests for Chlamydia organisms should not be used as a test of cure within 3 weeks after treatment. Use of urine assays for screening sexually active adolescents has the potential to significantly improve control of chlamydial infections.
About 4 million Chlamydia trachomatis urogenital infections
Chlamydial infections occur primarily among young sexually active persons. Prevalence crosses all socioeconomic occur in the United States annually [1, 2] . It has been estimated that ú50 million cases occur worldwide [2] . Infections are groups and may range from 5% to 20% in various groups of young adults [5, 9] . Because symptoms are absent in more than associated with many clinical syndromes, ranging from urethritis, proctitis, and epididymitis in men to cervicitis, salpingitis, half of infected persons, these prevalences may be grossly underestimated. Thus, widespread screening has been recomacute urethral syndrome, endometritis, ectopic pregnancy, infertility, and pelvic inflammatory disease (PID) in women and mended for persons at greatest risk: those who are young, who are sexually active, and who have new or multiple partners [1] . conjunctivitis and pneumonia in infants born to infected mothers [3 -5] . Unfortunately, symptoms are often mild or absent
Recently new molecular technologies that amplify the DNA of Chlamydia organisms in clinical specimens, such as polyamong infected men and women, creating a large reservoir of infected persons who continue transmission to new sex partners merase chain reaction (PCR) [10 -16] and ligase chain reaction (LCR) [17 -24] , have been found to offer expanded sensitivities [6] . Significant complications and sequelae also pose a significant economic burden on health care costs. About 1 million of detection over culture and other nonculture assays while maintaining high specificity. Clinical trials for PCR of 2861 cases of symptomatic PID are diagnosed annually in the United States, leading to 100,000 surgeries and ú275,000 hospitalizaurogenital specimens have demonstrated an overall sensitivity and specificity of 94.6% and 99.8%, respectively [25, 26] . tions yearly [7, 8] .
Similarly, LCR clinical trials for 4770 urogenital specimens, which also included urine specimens from female subjects, showed an overall sensitivity and specificity of 95% and 99.9%, respectively [27] . JID 1998; 177 (February) cessed urine specimens were tested by LCR for Neisseria gonorfied tests following adequate therapy, we tested urine specirhoeae according to the manufacturer's directions. No LCR testmens from high school female students by both PCR and LCR ing was done on cervical specimens because of the inability to and then enrolled infected students for follow-up urine testing obtain an additional swab from the cervix, as the first swab was after therapy. and PCR and LCR on urine specimens) were considered truly students presented to nurse practitioners at five Baltimore Centers infected, and those negative by all 3 tests were determined to be for Disease Control and Prevention-funded school-based clinics truly negative. For those discordant patient specimens, positive by for reproductive health care or genitourinary symptoms from Sep-1 test and negative by 2 others, a research PCR was done that tember 1995 through June 1996. All female students who attended targeted the OMP-1 gene instead of the gene segment from the the health clinics for either of these reasons were routinely screened cryptic plasmid, which was the target DNA for the commercial for chlamydial infections by PCR of cervical specimens (Roche assays [11] . Molecular Systems, Branchburg, NJ). Of these, 408 volunteered
Specimen reference standard. To compare only PCR and LCR to participate in this urine study. Another 35 students screened by of urine specimens, the reference standard was considered to be cervical PCR were not included in the study because they declined 2 positive of 3 amplification tests (PCR, LCR, OMP-1 research to participate or they did not provide the necessary urine specimen. PCR). Most students (91.2%) reported to the nurse practitioners for rouData were compiled in d-Base III/ (Ashton Tate, Borland Intertine reproductive health care. Only 6.1% reported symptoms, while national, Scotts Valley, CA) and analyzed using Intercooled Stata 2.7% reported contact with someone with a sexually transmitted 4.0 (Stata, College Station, TX). Univariate logistic regression and disease (STD) as a reason for the visit.
Fisher's exact test were used to determine which clinical signs and Before undergoing the pelvic examination for collection of swab symptoms were significantly associated with being Chlamydiaspecimens for gonorrhea culture and for PCR for Chlamydia DNA positive. Statistical significance was determined on the basis of P detection, a first-catch urine (the first part of the urine stream) õ .05. Odds ratios (ORs) and 95% confidence intervals (CIs) were specimen was provided by the subjects, who had not voided for calculated for each variable achieving a statistically significant 2 h previously, for testing by PCR and LCR (Abbott Laboratories, association with chlamydial infection. Abbott Park, IL). If either the PCR or the LCR urine test was positive, subjects were asked by the nurse practitioner to return every other school day to provide follow-up urine specimens for were coinfected with both C. trachomatis and N. gonorrhoeae. Only 1 of the 7 students treated with doxycycline provided follow-up specimens early after therapy. The other 6 provided Of those who had a positive Chlamydia test, 9.9% also had gonorrhea.
Results
specimens from 7 to ú21 days after therapy. The one who provided early specimens was positive by both PCR and LCR Persistence of positive urine results at follow-up. Thirtyeight infected subjects volunteered to be in the follow-up study at baseline but was negative by PCR and positive by LCR at days 3 and 5 after therapy. The next specimen was on day 7, and were enrolled. Of 33 evaluable students who provided timely specimens, 26 received single-dose azithromycin and 7
and both PCR and LCR were negative. The persistence of DNA in urine of patients who were treated with azithromycin received doxycycline for 7 days. Students testing positive who volunteered for follow-up were not different from those stuwas similar to that seen for the 1 patient treated with doxycycline who provided early specimens (figure 1). dents testing positive who did not volunteer by demographic characteristics, symptoms, signs, or risk factor history (data Of the 33 infected students who presented follow-up urine specimens, PCR on urine was positive for 33 (100%) at basenot shown). However, those students who volunteered for the follow-up study were less likely (9.4%) to have had a previous line, while LCR on urine was positive for 29 (87.9%). Several subjects with urine specimens negative at baseline by LCR diagnosis of C. trachomatis than were those students who did not volunteer (33.3%) (P Å .022).
subsequently had positive follow-up specimens. At 1 -3 days after therapy, PCR of urine specimens was positive for 40% and LCR was positive for 73.3%. By days 4 -6 after therapy, Chlamydial infections are highly prevalent in young sexually NOTE. PPV, positive predictive value; NPV, negative predictive value. n active adolescents. In this study of high school female students, confirmed positive test results. This inner city high school popof their high sensitivity, can be used for routine screening of noninvasive specimens, such as urine. The advantages of using ulation also demonstrated a high frequency of sexual risk behaviors, similar to those found in a national survey [30] . More urine as a diagnostic specimen are numerous: Urine is ideal for frequently screening asymptomatic persons, highly acceptthan half (53.1%) of all high school students in the United States have had sexual intercourse by age 18 [30] . This risk able to fearful students, and inexpensively collected in large numbers quickly. We have previously shown that use of amplibehavior and others, such as multiple partners and a new sex partner, have been shown in the past to be predictive of chlafied tests with urine specimens is cost-effective by use of a decision tree model [33] . mydial infection [31, 32] . Our study, in which all students reported being sexually active, confirmed the previous findings, In this study, the sensitivities of PCR and LCR on urine specimens for the detection of C. trachomatis were more sensisince 12.5% reported having ú1 sex partner and 13.5% reported having a new sex partner, and univariate analysis demtive than PCR on cervical specimens. The lower sensitivity of PCR on cervical specimens may be due to the presence of onstrated that both of the latter behaviors were associated with having a chlamydial infection. More than 66% did not consis-PCR inhibitors in cervical specimens, which has been noted by others [14] . Additionally, the cervical specimens may have tently use condoms, but this was not significantly associated with infection. Such multiple risk behaviors as those noted in been inadequate with respect to cellular columnar epithelial cells, which could have decreased the sensitivity of the cervical this group of adolescents place them at increased risk not only of chlamydial infections but also of other STDs. This was specimens. Both urine LCR and PCR had positive results that could not be confirmed with the urine OMP-1 research PCR, demonstrated in this study, since ú8% of the students admitted a previous diagnosis of gonorrhea, and urine testing for N.
leading to specificities of õ99% when only the urine specimen was considered. However, the OMP-1 PCR may be less sensigonorrhoeae in this study demonstrated a prevalence of 4.7%. Because 9.9% of those who had a positive test for chlamydial tive than the plasmid-based commercial assays. The sensitivity of cervical PCR was improved when 2 different urine amplifiinfection tested positive for gonorrhea, it appears prudent to perform urine screening of adolescents for both chlamydial cation assays were used as the reference standard, because fewer true-positive results were counted with this approach. A infection and gonorrhea whenever possible.
While 6.1% of enrolled students reported any symptoms, limitation of this study was that cell culture and LCR testing of the cervical specimen could not be done. only 9.9% of C. trachomatis -infected students reported symptoms. Because of the high prevalence and the virtually asympWith sexually active teens practicing high-risk behavior, frequent testing is ideal and offers multiple opportunities for edutomatic nature of chlamydial infections, a targeted outreach screening program in this population may have great potential cation and counseling by the health care worker. Increased frequency of screening adolescents has also been recommended to reduce the morbidity of sequelae such as PID and neonatal chlamydial infection. Molecular amplification assays, because in a recent study by Mosure et al. [34] . , who demonstrated that while none of 20 women first visit. In a preliminary study, we were able to calculate an incidence of chlamydial infection, by use of data from 2 years with chlamydial infection were culture-positive immediately after therapy, 10 had cervical specimens positive by a research of observation of 622 high school females (1105 visits), of 18.9/100 person-years of observation [35] . This high incidence PCR. In addition, 3 women had detectable chlamydial DNA by PCR of cervical specimens 1 week after therapy. supports annual screening of sexually active adolescents as a minimum, as indicated by Mosure et al. A better approach may Many other studies have demonstrated that nonculture Chlamydia antigen tests can remain positive after effective therapy be to screen more frequently than on an annual basis by testing urine specimens by DNA amplification.
[38 -43]. One report indicated that 6 (6.7%) of 36 direct fluorescent antibody tests remained positive at 7 -10 days after A limitation of our study was the inability to collect information on the treatment of the patients' sex partners; however, therapy with doxycycline, while none of these patients were still culture-positive [38] . Similarly, up to 10% of EIAs can the nurse practitioners did convey complete confidence after questioning that the female students did refrain from sexual remain positive 1 -3 weeks immediately after therapy that eradicated viable organisms [40, 43] . contact until they were told they tested negative for C. trachomatis.
Since PCR and LCR are much more sensitive than EIAs or direct fluorescent antibody tests, one would expect that DNA Some public health officials have raised several issues regarding use of urine as a diagnostic specimen, since a pelvic amplification tests would also remain positive longer after therapy than do culture tests, which measure viable organisms. examination might not be done and other medical conditions might be missed. For example, in this study, several clinical This has been demonstrated for cervical specimens but never for urine specimens with commercial assays, as demonstrated signs were found to be statistically associated with chlamydial infection. These included mucopus, cervicitis, cervical motion in this study. Vogels et al.
[44] compared cell culture and a research PCR for follow-up of swabs from 35 women and tenderness, and friability of the cervix. These signs would have been missed if no pelvic examination was done and only 35 men positive for C. trachomatis and found that, while all posttreatment specimens taken at 2 weeks after treatment with urine was screened. However, in this study only 1 student with chlamydial infection, who had a cervical specimen positive by doxycycline were culture-negative, the PCR test remained positive for 4.3% of patients. Conversely, Claas et al. [45] demon-PCR and 2 negative results of amplification assays on urine, would have been missed by not performing a pelvic examinastrated that there was no residual DNA detected by a research PCR for genital specimens from 32 patients 1 week after doxytion. Thus, while most would agree that symptomatic women require a pelvic examination, some investigators have recomcycline therapy. Since compliance in taking antibiotics is always an issue in eradicating organisms, it is of interest that mended that routine pelvic examinations in asymptomatic young women may not always be necessary, except for routine when Ossewaarde et al. [46] compared the efficacy of azithromycin versus doxycycline for the treatment of chlamydial cerPap smears [36] . In this era of cost containment, urine collection may prove to be cost-effective as a screening test [33] . vicitis, they found that chlamydial DNA could be detected in patients from both treatment groups. By identifying and treating more cases of chlamydial infection with frequent urine screening, even the more costly DNA In our follow-up study, the LCR test appeared to remain positive longer than the PCR test most of the time. Often, both amplification tests can be justified because of saving the significantly higher costs that would be associated with disease of the tests became negative in the same specimen, but at early time points the LCR test was the most delayed in reverting to sequelae, such as PID [33] . Screening and control programs have been shown to decrease the frequency of sequelae. It negative. One biologic explanation might be the fact that the target sequence of the DNA plasmid gene that is detected by was recently reported that screening and treating chlamydial infections in a health maintenance organization population PCR (207 bp) is larger than that for LCR (48 bp). As chlamydial DNA is degraded, perhaps the smaller DNA segments of the were associated with an Ç60% reduction of PID within a 1-year period [37] .
LCR target remain longer, while the larger segments of the PCR target are fragmented and thus are unavailable as uninterrupted While clinicians might potentially view urine as an ideal specimen to use for a test of cure for chlamydial infections, sequences for annealing of primers and subsequent amplification. caution must be exercised in using the test in this manner. Nucleic acid amplification assays can amplify nonviable chla-
In conclusion, chlamydial infections are highly prevalent in young adolescents. Since most are asymptomatic and the mydial DNA present in cervical epithelial cells that have not yet exfoliated. A positive test can result, even though the patient consequences of such infections can be so severe as to cause PID, ectopic pregnancy, and infertility, active screening is was successfully treated. This study demonstrated that both
